您当前所在的位置:首页 > 产品中心 > 产品详细信息
132-22-9 分子结构
点击图片或这里关闭

[3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine

ChemBase编号:985
分子式:C16H19ClN2
平均质量:274.78846
单一同位素质量:274.1236763
SMILES和InChIs

SMILES:
Clc1ccc(C(CCN(C)C)c2ncccc2)cc1
Canonical SMILES:
CN(CCC(c1ccccn1)c1ccc(cc1)Cl)C
InChI:
InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3
InChIKey:
SOYKEARSMXGVTM-UHFFFAOYSA-N

引用这个纪录

CBID:985 http://www.chembase.cn/molecule-985.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
[3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine
IUPAC传统名
hayon
商标名
Aller-Chlor
Allergican
Allergisan
Antagonate
Chlo-Amine
Chlor-Trimeton
Chlor-Trimeton Allergy
Chlor-Trimeton Repetabs
Chlor-Tripolon
Chlorate
Chloropiril
Cloropiril
Efidac 24 Chlorpheniramine Maleate
Gen-Allerate
Haynon
Histadur
Kloromin
Mylaramine
Novo-Pheniram
Pediacare Allergy Formula
Phenetron
Piriton
Polaramine
Polaronil
Pyridamal 100
Telachlor
Teldrin
别名
Chloropheniramine
Chlorophenylpyridamin
Chlorophenylpyridamine
Chloroprophenpyridamine
Chlorphenamine
Chlorpheniramine Maleate
Chlorprophenpyridamine
Clorfeniramina
Dexchlorpheniramine
Dexchlorpheniramine Maleate
Chlorpheniramine
CAS号
132-22-9
PubChem SID
46508253
160964448
PubChem CID
2725

数据来源

数据来源

所有数据来源 商品来源 非商品来源
数据来源 数据ID
DrugBank DB01114 external link
PubChem 2725 external link
数据来源 数据ID 价格

理论计算性质

理论计算性质

JChem ALOGPS 2.1
质子受体 质子供体
LogD (pH = 5.5) 0.20455076  LogD (pH = 7.4) 1.5225012 
Log P 3.584951  摩尔折射率 80.8503 cm3
极化性 31.551079 Å3 极化表面积 16.13 Å2
可自由旋转的化学键 里宾斯基五规则 true 
Log P 3.74  LOG S -3.72 
溶解度 5.19e-02 g/l 

分子性质

分子性质

理化性质 生物活性(PubChem)
溶解度
5.5 g/L expand 查看数据来源
疏水性(logP)
3.2 expand 查看数据来源

详细说明

详细说明

DrugBank DrugBank
DrugBank -  DB01114 external link
Item Information
Drug Groups approved
Description A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than promethazine. [PubChem]
Indication For the treatment of rhinitis, urticaria, allergy, common cold, asthma and hay fever.
Pharmacology In allergic reactions an allergen interacts with and cross-links surface IgE antibodies on mast cells and basophils. Once the mast cell-antibody-antigen complex is formed, a complex series of events occurs that eventually leads to cell-degranulation and the release of histamine (and other chemical mediators) from the mast cell or basophil. Once released, histamine can react with local or widespread tissues through histamine receptors. Histamine, acting on H1-receptors, produces pruritis, vasodilatation, hypotension, flushing, headache, tachycardia, and bronchoconstriction. Histamine also increases vascular permeability and potentiates pain. Chlorpheniramine, is a histamine H1 antagonist (or more correctly, an inverse histamine agonist) of the alkylamine class. It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.
Toxicity Oral LD50 (rat): 306 mg/kg; Oral LD50 (mice): 130 mg/kg; Oral LD50 (guinea pig): 198 mg/kg [Registry of Toxic Effects of Chemical Substances. Ed. D. Sweet, US Dept. of Health & Human Services: Cincinatti, 2010.]
Also a mild reproductive toxin to women of childbearing age.
Affected Organisms
Humans and other mammals
Biotransformation Primarily hepatic via Cytochrome P450 (CYP450) enzymes.
Absorption Well absorbed in the gastrointestinal tract.
Half Life 21-27 hours
Protein Binding 72%
References
* [MSDS]
External Links
Wikipedia
RxList
Drugs.com

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle